Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment

J Cardiovasc Med (Hagerstown). 2017 Oct;18(10):771-773. doi: 10.2459/JCM.0000000000000244.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Biomarkers / blood
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Cystatin C / blood*
  • Female
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Humans
  • Hydrazones / pharmacology
  • Hydrazones / therapeutic use*
  • Kidney / drug effects*
  • Male
  • Pyridazines / pharmacology
  • Pyridazines / therapeutic use*
  • Renal Insufficiency / blood
  • Renal Insufficiency / complications*
  • Simendan

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Cystatin C
  • Hydrazones
  • Pyridazines
  • Simendan